Envestnet Asset Management’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-18,412
| Closed | -$3.17M | – | 3993 |
|
|
2021
Q3 | $3.17M | Buy |
18,412
+274
| +2% | +$35.8K | ﹤0.01% | 1800 |
|
|
2021
Q2 | $2.28M | Buy |
18,138
+398
| +2% | +$50.2K | ﹤0.01% | 1967 |
|
|
2021
Q1 | $2.41M | Buy |
17,740
+1,633
| +10% | +$211K | ﹤0.01% | 1832 |
|
|
2020
Q4 | $2.06M | Buy |
16,107
+1,036
| +7% | +$121K | ﹤0.01% | 1742 |
|
|
2020
Q3 | $1.7M | Buy |
15,071
+10,629
| +239% | +$1.06M | ﹤0.01% | 1714 |
|
|
2020
Q2 | $423K | Sell |
4,442
-513
| -10% | -$49.5K | ﹤0.01% | 2502 |
|
|
2020
Q1 | $445K | Sell |
4,955
-2,086
| -30% | -$162K | ﹤0.01% | 2318 |
|
|
2019
Q4 | $373K | Buy |
7,041
+1,227
| +21% | +$55.9K | ﹤0.01% | 2635 |
|
|
2019
Q3 | $230K | Buy |
5,814
+69
| +1% | +$2.99K | ﹤0.01% | 2807 |
|
|
2019
Q2 | $236K | Buy |
5,745
+422
| +8% | +$17.5K | ﹤0.01% | 2810 |
|
|
2019
Q1 | $248K | Sell |
5,323
-372
| -7% | -$16.3K | ﹤0.01% | 2721 |
|
|
2018
Q4 | $248K | Buy |
+5,695
| New | +$285K | ﹤0.01% | 2537 |
|
|
2018
Q3 | – | Sell |
-506
| Closed | -$25K | – | 2875 |
|
|
2018
Q2 | $25K | Sell |
506
-86
| -15% | -$3.13K | ﹤0.01% | 2377 |
|
|
2018
Q1 | $23K | Buy |
592
+33
| +6% | +$1.4K | ﹤0.01% | 2336 |
|
|
2017
Q4 | $24K | Sell |
559
-94
| -14% | -$3.53K | ﹤0.01% | 2493 |
|
|
2017
Q3 | $25K | Sell |
653
-2,654
| -80% | -$92.1K | ﹤0.01% | 2454 |
|
|
2017
Q2 | $101K | Buy |
3,307
+164
| +5% | +$4.75K | ﹤0.01% | 2132 |
|
|
2017
Q1 | $83K | Sell |
3,143
-688
| -18% | -$18.1K | ﹤0.01% | 2254 |
|
|
2016
Q4 | $98K | Sell |
3,831
-258
| -6% | -$8.18K | ﹤0.01% | 2190 |
|
|
2016
Q3 | $148K | Sell |
4,089
-159
| -4% | -$5.27K | ﹤0.01% | 2164 |
|
|
2016
Q2 | $144K | Buy |
4,248
+1,177
| +38% | +$38.3K | ﹤0.01% | 2269 |
|
|
2016
Q1 | $81K | Sell |
3,071
-367
| -11% | -$10.7K | ﹤0.01% | 2504 |
|
|
2015
Q4 | $168K | Buy |
3,438
+636
| +23% | +$22.9K | ﹤0.01% | 2129 |
|
|
2015
Q3 | $70K | Buy |
+2,802
| New | +$84.2K | ﹤0.01% | 2499 |
|
Envestnet Asset Management's XLRN Position: Q4 2021 in Review
Envestnet Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 18,412 shares — an estimated $3.17M sold.
Envestnet Asset Management first reported a position in XLRN in Q3 2015 and held it in 24 quarters. The position peaked at $3.17M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Envestnet Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Envestnet Asset Management sold 18,412 Acceleron Pharma shares in Q4 2021, an estimated $3.17M.
- Envestnet Asset Management first reported a position in Acceleron Pharma in Q3 2015 and held it in 24 quarters.
- Envestnet Asset Management's Acceleron Pharma position peaked at $3.17M in Q3 2021.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Envestnet Asset Management's 13F filing for Q4 2021, filed 4 Feb 2022.